Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
A versatile product: FDA approves botulinum toxin for glabellar lines
Irvine, CA-The FDA has approved the use of botulinum toxin type A (Botox, Allergan, Irvine, CA) for temporary improvement in the appearance of moderate to severe glabellar lines in adult men and women 65 or younger.
Related Videos
Related Content
